Bill Few Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.26M | Sell |
33,729
-1,052
| -3% | -$195K | 1.77% | 9 |
|
2025
Q1 | $7.29M | Sell |
34,781
-34
| -0.1% | -$7.12K | 2.6% | 5 |
|
2024
Q4 | $6.19M | Buy |
34,815
+481
| +1% | +$85.5K | 2.17% | 8 |
|
2024
Q3 | $6.78M | Buy |
34,334
+43
| +0.1% | +$8.49K | 2.41% | 6 |
|
2024
Q2 | $5.88M | Sell |
34,291
-390
| -1% | -$66.9K | 2.26% | 8 |
|
2024
Q1 | $6.32M | Buy |
34,681
+558
| +2% | +$102K | 2.56% | 5 |
|
2023
Q4 | $5.29M | Sell |
34,123
-396
| -1% | -$61.4K | 2.41% | 7 |
|
2023
Q3 | $5.15M | Buy |
34,519
+474
| +1% | +$70.7K | 2.69% | 7 |
|
2023
Q2 | $4.59M | Sell |
34,045
-486
| -1% | -$65.5K | 2.37% | 10 |
|
2023
Q1 | $5.5M | Buy |
34,531
+465
| +1% | +$74.1K | 3.06% | 3 |
|
2022
Q4 | $5.51M | Sell |
34,066
-259
| -0.8% | -$41.9K | 3.25% | 4 |
|
2022
Q3 | $4.61M | Sell |
34,325
-2,327
| -6% | -$312K | 3.12% | 4 |
|
2022
Q2 | $5.61M | Sell |
36,652
-733
| -2% | -$112K | 3.59% | 3 |
|
2022
Q1 | $6.06M | Buy |
37,385
+125
| +0.3% | +$20.3K | 3.3% | 3 |
|
2021
Q4 | $5.05M | Buy |
+37,260
| New | +$5.05M | 2.61% | 7 |
|